Voyageur Pharmaceuticals (CVE:VM) Shares Up 21.2% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price was up 21.2% on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares were traded during trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Up 21.2 %

The stock has a market capitalization of C$27.89 million, a PE ratio of -20.00 and a beta of 0.32. The business’s 50-day moving average is C$0.10 and its two-hundred day moving average is C$0.07. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.